26 May 2013
Keywords: gsk, secures, additional, indication, coreg, fda, panel
Article | 13 January 2003
The US Food and Drug Administration's Cardiovascular and Renal DrugsAdvisory Committee voted unanimously January 7 to back an expanded use
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 January 2003
24 May 2013
© 2013 thepharmaletter.com